BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 22448030)

  • 1. Methylation of human papillomavirus type 16 genome and risk of cervical precancer in a Costa Rican population.
    Mirabello L; Sun C; Ghosh A; Rodriguez AC; Schiffman M; Wentzensen N; Hildesheim A; Herrero R; Wacholder S; Lorincz A; Burk RD
    J Natl Cancer Inst; 2012 Apr; 104(7):556-65. PubMed ID: 22448030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HPV16 CpG methyl-haplotypes are associated with cervix precancer and cancer in the Guanacaste natural history study.
    Frimer M; Sun C; McAndrew T; Smith B; Harari A; Chen Z; Mirabello L; Wentzensen N; Goldberg GL; Rodriguez AC; Schiffman M; Burk RD
    Gynecol Oncol; 2015 Jul; 138(1):94-100. PubMed ID: 26001326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylation of HPV16 genome CpG sites is associated with cervix precancer and cancer.
    Sun C; Reimers LL; Burk RD
    Gynecol Oncol; 2011 Apr; 121(1):59-63. PubMed ID: 21306759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated methylation of HPV16 DNA is associated with the development of high grade cervical intraepithelial neoplasia.
    Mirabello L; Schiffman M; Ghosh A; Rodriguez AC; Vasiljevic N; Wentzensen N; Herrero R; Hildesheim A; Wacholder S; Scibior-Bentkowska D; Burk RD; Lorincz AT
    Int J Cancer; 2013 Mar; 132(6):1412-22. PubMed ID: 22847263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence.
    Kjær SK; Frederiksen K; Munk C; Iftner T
    J Natl Cancer Inst; 2010 Oct; 102(19):1478-88. PubMed ID: 20841605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparing the performance of FAM19A4 methylation analysis, cytology and HPV16/18 genotyping for the detection of cervical (pre)cancer in high-risk HPV-positive women of a gynecologic outpatient population (COMETH study).
    Luttmer R; De Strooper LM; Berkhof J; Snijders PJ; Dijkstra MG; Uijterwaal MH; Steenbergen RD; van Kemenade FJ; Rozendaal L; Helmerhorst TJ; Verheijen RH; Ter Harmsel WA; Van Baal WM; Graziosi PG; Quint WG; Heideman DA; Meijer CJ
    Int J Cancer; 2016 Feb; 138(4):992-1002. PubMed ID: 26317579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.
    Castle PE; Stoler MH; Wright TC; Sharma A; Wright TL; Behrens CM
    Lancet Oncol; 2011 Sep; 12(9):880-90. PubMed ID: 21865084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk stratification of HPV 16 DNA methylation combined with E6 oncoprotein in cervical cancer screening: a 10-year prospective cohort study.
    Dong L; Zhang L; Hu SY; Feng RM; Zhao XL; Zhang Q; Pan QJ; Zhang X; Qiao YL; Zhao FH
    Clin Epigenetics; 2020 May; 12(1):62. PubMed ID: 32381054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylation of twelve CpGs in human papillomavirus type 16 (HPV16) as an informative biomarker for the triage of women positive for HPV16 infection.
    Brandsma JL; Harigopal M; Kiviat NB; Sun Y; Deng Y; Zelterman D; Lizardi PM; Shabanova VS; Levi A; Yaping T; Hu X; Feng Q
    Cancer Prev Res (Phila); 2014 May; 7(5):526-33. PubMed ID: 24556390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylation of HPV18, HPV31, and HPV45 genomes and cervical intraepithelial neoplasia grade 3.
    Wentzensen N; Sun C; Ghosh A; Kinney W; Mirabello L; Wacholder S; Shaber R; LaMere B; Clarke M; Lorincz AT; Castle PE; Schiffman M; Burk RD
    J Natl Cancer Inst; 2012 Nov; 104(22):1738-49. PubMed ID: 23093560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of cervical precancer with human papillomavirus types other than 16 among HIV co-infected women.
    Massad LS; Xie X; Burk RD; D'Souza G; Darragh TM; Minkoff H; Colie C; Burian P; Palefsky J; Atrio J; Strickler HD
    Am J Obstet Gynecol; 2016 Mar; 214(3):354.e1-6. PubMed ID: 26433170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylation marker analysis and HPV16/18 genotyping in high-risk HPV positive self-sampled specimens to identify women with high grade CIN or cervical cancer.
    Verhoef VM; Heideman DA; van Kemenade FJ; Rozendaal L; Bosgraaf RP; Hesselink AT; Bekkers RL; Massuger LF; Steenbergen RD; Snijders PJ; Berkhof J; Meijer CJ
    Gynecol Oncol; 2014 Oct; 135(1):58-63. PubMed ID: 25111387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel human papillomavirus and host DNA methylation score and detection of cervical adenocarcinoma.
    Gradissimo A; Clarke MA; Xue X; Castle PE; Raine-Bennett TR; Schiffman M; Wentzensen N; Strickler HD; Burk RD
    J Natl Cancer Inst; 2023 Dec; 115(12):1535-1543. PubMed ID: 37467068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inverse association between methylation of human papillomavirus type 16 DNA and risk of cervical intraepithelial neoplasia grades 2 or 3.
    Xi LF; Jiang M; Shen Z; Hulbert A; Zhou XH; Lin YY; Kiviat NB; Koutsky LA
    PLoS One; 2011; 6(8):e23897. PubMed ID: 21887341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A DNA methylation classifier of cervical precancer based on human papillomavirus and human genes.
    Brentnall AR; Vasiljević N; Scibior-Bentkowska D; Cadman L; Austin J; Szarewski A; Cuzick J; Lorincz AT
    Int J Cancer; 2014 Sep; 135(6):1425-32. PubMed ID: 24535756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors.
    Arbyn M; Xu L; Simoens C; Martin-Hirsch PP
    Cochrane Database Syst Rev; 2018 May; 5(5):CD009069. PubMed ID: 29740819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human papillomavirus type 16 infections and 2-year absolute risk of cervical precancer in women with equivocal or mild cytologic abnormalities.
    Castle PE; Solomon D; Schiffman M; Wheeler CM
    J Natl Cancer Inst; 2005 Jul; 97(14):1066-71. PubMed ID: 16030304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High load for most high risk human papillomavirus genotypes is associated with prevalent cervical cancer precursors but only HPV16 load predicts the development of incident disease.
    Gravitt PE; Kovacic MB; Herrero R; Schiffman M; Bratti C; Hildesheim A; Morales J; Alfaro M; Sherman ME; Wacholder S; Rodriguez AC; Burk RD
    Int J Cancer; 2007 Dec; 121(12):2787-93. PubMed ID: 17722112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HPV16 L1 and L2 DNA methylation predicts high-grade cervical intraepithelial neoplasia in women with mildly abnormal cervical cytology.
    Lorincz AT; Brentnall AR; Vasiljević N; Scibior-Bentkowska D; Castanon A; Fiander A; Powell N; Tristram A; Cuzick J; Sasieni P
    Int J Cancer; 2013 Aug; 133(3):637-44. PubMed ID: 23335178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative Measurement of L1 Human Papillomavirus Type 16 Methylation for the Prediction of Preinvasive and Invasive Cervical Disease.
    Kottaridi C; Kyrgiou M; Pouliakis A; Magkana M; Aga E; Spathis A; Mitra A; Makris G; Chrelias C; Mpakou V; Paraskevaidis E; Panayiotides JG; Karakitsos P
    J Infect Dis; 2017 Mar; 215(5):764-771. PubMed ID: 28170039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.